What question did this study set out to answer?

The aim is to analyze the trend of medical costs for primary biliary cholangitis patients over 20 years.

April 18, 2026Hepatology Research0 citations

Medical Costs Increase Over Time for Primary Biliary Cholangitis Patients: A 20‐Year Population‐Based Study

JCJur‐Shan ChengChang Gung University WCWei‐Ting ChenChang Gung University TCTsung‐Hsing ChenChang Gung University

Key Points

The aim is to analyze the trend of medical costs for primary biliary cholangitis patients over 20 years.
Analyzed medical costs over a 20-year period for PBC patients.
Examined both inpatient and outpatient costs.
Identified specific subgroups with increased costs.
Proposed interventions for cost reduction.
Total and mean outpatient costs for PBC patients rose over the study period.
Subgroups at higher risk for increased costs include males, elderly patients, and those with diabetes.
A suggested new drug costing ≤ NTD 20,417/year could benefit Taiwanese PBC patients.

Abstract

The overall (total, inpatient and outpatient) and mean outpatient costs for PBC patients increased over time. Special attention and tailored treatments should be given to PBC subgroups, including males, elderly people, southern Taiwan residents, those with hepatic events, and those with diabetes, as this approach might effectively reduce medical costs. A new drug that is effective and costs ≤ NTD 20,417/year would benefit PBC patients in Taiwan.

问 AI

Bookmark

View Full Paper